Clinical Trial Update: Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating liposomal daunorubicin for metastatic breast cancer. The document provides trial information with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Liposomal daunorubicin (daunorubicin liposome)

Snippet

Sponsor: University of Leicester | Conditions: Breast Cancer | Phase 1 | Status: UNKNOWN